1. |
中华医学会呼吸病学分会间质性肺病学组. 特发性肺纤维化急性加重诊断和治疗中国专家共识. 中华医学杂志, 2019, 99(26): 2014-2023.
|
2. |
雷凯春, 岳红梅, 周婷婷. 特发性肺纤维化治疗新进展. 中国呼吸与危重监护杂志, 2019, 18(2): 199-203.
|
3. |
赵蓉, 吕凌. 甘草酸二铵药理研究和临床应用进展. 亚太传统医药, 2008, 4(3): 31-36.
|
4. |
秦刚, 施光峰, 宋艳艳, 等. 甘草酸二铵治疗慢性乙型肝炎 3201 例荟萃分析. 中华传染病杂志, 2005, 23(5): 333-337.
|
5. |
方妮, 周鸿江, 陈俊健. 甘草酸二铵对稳定期慢性阻塞性肺疾病的临床疗效及对患者血清炎性因子和外周血 T 淋巴细胞水平的影响. 中国医药, 2019, 14(9): 1326-1330.
|
6. |
李峥, 黄华, 陈凤坤, 等. 甘草酸二铵与黄芪注射液治疗急性肺损伤疗效分析. 中国中西医结合急救杂志, 2013, 20(4): 213-215.
|
7. |
韩美玉, 韩志远. 甘草酸二铵佐治支气管哮喘对肺功能、气道炎症和免疫功能的影响. 中国药业, 2018, 27(18): 56-58.
|
8. |
黄坤, 吴晓梅, 王欣燕, 等. 骨髓间充质干细胞向肺泡细胞转化的实验研究. 中国呼吸与危重监护杂志, 2011, 10(6): 572-576.
|
9. |
崔瑷, 代华平, 戴建武, 等. 骨髓间充质干细胞对博来霉素致大鼠肺纤维化形成的影响. 中华结核和呼吸杂志, 2007, 30(9): 677-682.
|
10. |
Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis, 1979, 120(4): 893-899.
|
11. |
Mokhber Dezfouli MR, Sadeghian Chaleshtori S, Moradmand A, et al. Hydrocortisone promotes differentiation of mouse embryonic stem cell-derived definitive endoderm toward lung alveolar epithelial cells. Cell J, 2019, 20(4): 469-476.
|
12. |
中华医学会呼吸病学分会间质性肺疾病学组. 特发性肺纤维化诊断和治疗中国专家共识. 中华结核和呼吸杂志, 2016, 39(6): 427-432.
|
13. |
Yoon HY, Park S, Kim DS, et al. Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis. Respir Res, 2018, 19(1): 203-213.
|
14. |
Varone F, Sgalla G, Lovene B, et al. Nintedanib for the treatment of idiopathic pulmonary fibrosis. Expert Opin Pharmacother, 2018, 19(2): 167-175.
|
15. |
Tepede A, Yogaratnam D. Nintedanib for idiopathic pulmonary fibrosis. J Pharm Pract, 2019, 32(2): 199-206.
|
16. |
Kumar A, Kapnadak SG, Girgis RE, et al. Lung transplantation in idiopathic pulmonary fibrosis. Expert Rev Respir Med, 2018, 12(5): 375-385.
|
17. |
金晓光, 代华平, 庞宝森, 等. 博来霉素致大鼠肺纤维化模型肺组织的动态病理变化及其发生机制. 中国病理生理杂志, 2009, 25(4): 708-714.
|
18. |
柴文戍, 李永春, 刘玉玲, 等. 博来霉素致肺纤维化大鼠形态学变化的实验研究. 中国实验动物学报, 2003, 11(2): 77-80.
|
19. |
Demkow U. Immunopathogenesis of idiopathic pulmonary fibrosis. Pneumonol Alergol Pol, 2014, 82(1): 55-60.
|
20. |
黄坤, 吴晓梅, 王欣燕, 等. 骨髓间充质干细胞移植对大鼠肺纤维化的影响. 中华结核和呼吸杂志, 2012, 35(9): 659-664.
|
21. |
Krähenbühl S, Hasler F, Frey BM, et al. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab, 1994, 78(3): 581-585.
|
22. |
Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res, 2008, 22(6): 709-724.
|
23. |
Li Y, Liu TY, Yan C, et al. Diammonium glycyrrhizinate protects against nonalcoholic fatty liver disease in mice through modulation of gut microbiota and restoration of intestinal barrier. Mol Pharm, 2018, 15(9): 3860-3870.
|
24. |
Zhao X, Liu J, Yang S, et al. Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats. Eur J Pharmacol, 2017, 15(7): 144-150.
|